Misplaced Pages

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Misplaced Pages's content policies, particularly neutral point of view. Please discuss further on the talk page. (June 2010) (Learn how and when to remove this message) The topic of this article may not meet Misplaced Pages's notability guidelines for products and services. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources: "Niquitin" – news · newspapers · books · scholar · JSTOR (September 2024) (Learn how and when to remove this message) This article needs more reliable medical references for verification or relies too heavily on primary sources. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed. Find sources: "Niquitin" – news · newspapers · books · scholar · JSTOR (August 2024) Some of this article's listed sources may not be reliable. Please help improve this article by looking for better, more reliable sources. Unreliable citations may be challenged and removed. (September 2024) (Learn how and when to remove this message) (Learn how and when to remove this message)

NiQuitin is a range of nicotine replacement products designed to help smokers quit by replacing the nicotine supplied by cigarettes with a lower, steadier level in order to relieve withdrawal. This is to help users wean off nicotine gradually. Nicotine replacement therapy products (e.g. chewing gum, lozenges, transdermal systems) are indicated as temporary aids for cigarette smokers who want to give up smoking. They serve as alternative sources of nicotine and provide relief of nicotine withdrawal symptoms in nicotine-dependent individuals who are acutely withdrawing from cigarette smoking.

History

Created by GlaxoSmithKline, NiQuitin was approved by the FDA in 1991, one of the earliest products brought to market to provide an alternative to the withdrawal symptoms of quitting smoking. Nicotine gums were already widely used among consumers.

The product is sold globally under different brand names such as Nicoderm in the US, Nicabate in Australia and New Zealand and NiQuitin CQ in China, many parts of Europe and South America.

References

1. "Wiley Interscience".
2. "About Nicoderm CQ & Nicotine Replacement Therapy". Archived from the original on 2008-12-18. Retrieved 2008-12-16.
3. "PharmGKB". PharmGKB.
4. "10/28/96 READY TO TOSS THOSE CANCER STICKS?". www.businessweek.com. Archived from the original on 2000-01-23.
5. "GlaxoSmithKline: NiQuitin". Archived from the original on 2008-12-16. Retrieved 2008-12-16.

External links

• Nicoderm CQ
• Niquitin
• Nicabate
• GSK Product Information

• Smoking cessation
• Haleon brands